Ludwig Cancer Research is an international community of distinguished scientists dedicated to preventing and controlling cancer. American businessman Daniel K. Ludwig began to support cancer research with the establishment of the Ludwig Institute for Cancer Research in 1971. Today, the scientific efforts endowed through his resources have grown to encompass the Ludwig Institute and the Ludwig Centers at six U.S. institutions, all pursuing breakthroughs to alter the course of cancer.
The LICR Fund Inc. is a US 501(c)3 organization that manages the assets of the Ludwig Institute for Cancer Research.
The LICR Fund's investment goal is to provide for sustainable core spending for the Ludwig Institute while maintaining the purchasing power of the Fund for future generations of scientists. The Fund, valued currently at $1.3 billion, is overseen by a Board of Directors, which determines investment policy and objectives, defines guidelines for the allocation of assets and—together with the Institute's Investment Office—appoints and evaluates outside investment managers.
The Fund's orientation is global and broadly diversified, with an investment portfolio incorporating a range of asset classes and strategies designed to achieve its risk-adjusted objectives.
To make a tax-deductible donation in support of Ludwig's singular focus on cancer, please e-mail here.
CONTACT THE AUDIT COMMITTEE
Reports of concerns and violations of any type can be submitted to the Audit Committee of the Institute's Board of Directors. All correspondence will be kept confidential. Reports can be submitted anonymously. The Audit Committee can be contacted by clicking here.